Nature Reviews Urology

Article	Citations
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything	222
Texture analysis for patient selection	210
Single-cell and spatial sequencing of kidney cancer	158
Human-relevant urothelial model provides insight into infection strategies and host response	143
Krause corpuscles act as genital vibration detectors	129
Semen quality recovery following COVID-19	102
PARP inhibitors plus enzalutamide to treat mCRPC	86
Urine microbiota differ in bladder cancer	81
Considering urology in a planetary context	80
Time for women-centred gynaecology	76
The clinical utility of prostate MRI before biopsy	75
Advancing the state of the art in congenital obstructive uropathy	75
Symptoms and subtypes of patients with lower urinary tract dysfunction — insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network	73
Preclinical models of bladder cancer: BBN and beyond	72
High-dose chemotherapy for relapsed testicular germ cell tumours	66
A clinical guide to rare male sexual disorders	62
Micro-ultrasound for prostate cancer	60
FOXA2–KIT-driven lineage plasticity in NEPC	58
Proteomic-based analysis of testicular interstitial fluid	58
Overcoming antibiotic resistance in complicated UTI	57
A new text message-based platform for self-management of patients with IC/BPS	57
Madrid plays host to a celebration of urology	55
What happens in Vegas … shapes the future of urology	53
Microfluidic sperm selection	51
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations	50

Leveraging generative AI to enhance doctor–patient communication	50
Promise without practice — charting the path forward for bladder cancer biomarkers	50
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer	48
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers	48
Metaverse in surgery — origins and future potential	47
Pembrolizumab + axitinib beyond first-line therapy for mRCC	46
A non-invasive assay for UTUC diagnosis	46
COVID can’t kill CopMich collaboration	43
Vaccination to prevent untreatable gonorrhoea	42
The mechanism of action of neuromodulation in the treatment of overactive bladder	41
Persistent Müllerian duct syndrome — a rare but important cause of male factor infertility	41
Measuring and improving the cradle-to-grave environmental performance of urological procedures	41
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology	37
Personalized 3D models for prostate cancer surgery	37
Resolving the puzzle of same-sex sexual interactions	36
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications	36
PEACEing together prostate cancer therapy	36
Efficacy of the Revi system in treating urgency urinary incontinence	36
EMUC25: shaping tomorrow’s uro-oncology care	35
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment	34
Transitional urology: a comprehensive review of the transitional care process	33
Mohs micrographic surgery and reconstruction for glans and urethral squamous cell carcinoma	33
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence	32
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway	32
Effect of high glucose on E. coli	32
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC	31
Women in urology: the past	29
Cribriform morphology affects mpMRI imaging	29
The magic of MagSToNE	29
Promising efficacy of UTI vaccines as an alternative to antibiotics	28
AUA returns to its former glory in Chicago	28
Robots learning to imitate surgeons — challenges and possibilities	28
A distinct TAM subset mediates immunotherapy resistance in prostate cancer	28
Videourodynamics — role, benefits and optimal practice	27
Technical modifications to improve erectile function recovery after radical prostatectomy	27
A clinical overview of people living with HIV and genitourinary cancer care	26
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?	26
Successful mentorship for women in urology — a new era	26
Microultrasonography-guided prostate cancer biopsy	26
Excluding PLND in favourable intermediate-risk prostate cancer: a PSMA-PET-directed perspective	25
Prostate cancer in transgender women — challenges in research and clinical care	24
Secondary kidney stones — remove or leave?	24
Is it time to rethink the current patient-reported outcome measures?	23
Current and emerging strategies to curb antibiotic-resistant urinary tract infections	23
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer	22
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease	21
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD	20
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards	20
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer	20
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer	20

Management and cost of stent encrustation in pregnancy	19
De-clear cell differentiated renal cell carcinoma — a new therapeutic target	19
Pride, not prejudice	19
Turning up the heat: CTLA4 blockade in urothelial cancer	18
AI for antibiotic design	18
Beyond maternal exercise: paternal exercise adaptations mediated by sperm microRNA signatures	17
Epigenetic modulation of prostate cancer disparities in men with African ancestry	17
The evolving treatment landscape of metastatic urothelial cancer	16
The future of patient-derived xenografts in prostate cancer research	16
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning	16
The prognostic role of stroma in UTUC	16
Fathers matter too: sperm-borne epigenetic messages link paternal exposures to next-generation health	16
What is new in the updated National Institute for Health and Care Excellence (NICE) fertility problems guideline 2026?	16
The value of women urologists — individual and institutional imperatives to address salary equity	16
Turning back time in the testes	15
Uncovering a link between COVID-19 and renal cell carcinoma	15
Pelvic-fascia-sparing techniques and outcomes with RARP	15
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer	14
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself	14
New evidence and novel techniques for assessing intraoperative margins during radical prostatectomy	14
Och AI the noo from SIU	14
We all get erections — de-gendering sexual arousal dysfunction in the ICD	14
Improved phenotypic classification of male infertility to promote discovery of genetic causes	13
Urinary tract infections in children	13
Hallmark discoveries in the biology of Wilms tumour	13
Current and future pharmacotherapy for female sexual dysfunction	13
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome	12
CMA mediates resistance to androgen inhibitors in prostate cancer	12
Men hold the balance of power	12
Power up to investigate PrEP	12
The shifting treatment paradigm of metastatic renal cell carcinoma	12
Mechanisms of the intestinal and urinary microbiome in kidney stone disease	11
Male infertility and somatic health — insights into lipid damage as a mechanistic link	11
Diagnosis of ccRCC	11
Spatiotemporal trends in human semen quality	11
Mellow yellow: BilR reduces bilirubin to urobilinogen	11
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer	11
Author Correction: Atypical intraductal proliferation in prostate biopsy — a diagnostic grey zone with clinical implications	11
Metabolism, mitochondria and metastasis in kidney cancer	11
Tuft cells in prostate cancer	11
MRI diagnosis and radical prostatectomy outcomes	10
Chlorination by-products in drinking water — association with bladder cancer risk	10
The ins and outs of penile erection	10
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI	10
Pronouns in English: a user’s guide	10
Sperm activity affected by endometriosis	10
Advances in sliding clip renorrhaphy for partial nephrectomy	10
Semen parameters across testicular cancer stages	10
Stepping up to prevent bacterial vaginosis recurrence	10
Syphilis on the rise — a need for alternative therapies and vaccines	10
Artificial intelligence in the management of prostate cancer	9
A great gathering at the 4th Clinical and Scientific Advances in UTI conference	9
Pathophysiology and potential multimodal therapeutic strategies for IC/BPS	9
Urology on a changing planet: links between climate change and urological disease	9
Particulate matter leaves a bitter taste in testes	9
Visual clues — dermatological manifestations of sexually transmitted infections in men	9
Testosterone replacement therapy and spermatogenesis in reproductive age men	9
Clinical trial design for non-muscle-invasive bladder cancer	8
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma	8
EAU26: innovation, patient care and a touch of mythology	8
Feasibility and potential of an MRI-based prostate cancer screening	8
Influence of substance use on male reproductive health and offspring outcomes	8
Smooth muscle cell plasticity in pelvic organ prolapse	8
Genetic and biological drivers of prostate cancer disparities in Black men	8
Art, science and clinical urology with a Capitol AUA	7
Being a non-native English speaker in science and medicine	7
ADT intensification to treat biochemically recurrent prostate cancer	7
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects	7
Pregnancy and parental leave in medicine and academia — a focus on urology	7
Publisher Correction: HER2 in urothelial cancer: clinical speed outpacing diagnostic clarity	7
The future of pelvic lymph node dissection for urological malignancies	7
Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia	7
Neurogenic lower urinary tract dysfunction in ageing men with spinal cord injury	7
Prescribing clinician specialty influences adherence to PrEP	7
The prostatic middle lobe: clinical significance, presentation and management	6
New insights into APOBEC-mediated mutagenesis in prostate cancer	6
Gut microbiome’s effect on immunotherapy response	6
Sexual transfer of bacteria for forensic use	6
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma	6
An app for optimizing UTI screening	6

Landmarks in the evolution of prostate biopsy	5
Adjuvant immunotherapy for renal cell carcinoma: understanding complexity, embracing uncertainty, making a difference	5
Prostate cancer epigenetics — from pathophysiology to clinical application	5
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications	5
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer	5
A urologist as a urological patient	5
Non-human primates as a translational model for the study of male reproductive health	5
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment	5
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury	4
A vagina on a chip to model microbiome–host interactions	4
Iatrogenic upper urinary tract injuries during ureteroscopy for urolithiasis: a comprehensive review on incidence, mechanisms and preventative strategies	4
The urinary microbiome, overactive bladder and bladder pain syndrome/interstitial cystitis — mechanisms, diagnostics and therapeutic opportunities	4
Advancing perioperative care in MIBC: insights from NIAGARA	4
SRD5A2 and emerging therapies in androgen-driven disorders	4
Should we screen for sleep apnoea in men with idiopathic infertility?	4
The effect of red blood cell disorders on male fertility and reproductive health	4
Clinical hypnosis improves LUTS	4
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer	4
The role of CFTR in spermatogenesis and sperm quality	4
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research	4
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care	4
Metabolic alterations drive enzalutamide resistance	4
Metastasis development in non-muscle-invasive bladder cancer	4
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence	4
The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers	3
Accessing information in the AI age	3
Utility of PSA screening in transgender women receiving oestrogens	3
Human sperm RNA in male infertility	3
Reply to ‘Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence’	3
Generative AI in scientific publishing: disruptive or destructive?	3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?	3
Health-related quality of life after curative treatment for muscle-invasive bladder cancer	3
Targeting TGCT	3
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy	3
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC	3
Mapping the human prostate at the cellular level	3
A new surgical procedure to treat BPH	3
Immunoliposome targeting IL-30	3
From foes to friends: rethinking the role of lymph nodes in prostate cancer	3
Proteomic characterization of bladder cancer	3
Emerging evidence for sequencing and combining PSMA-based therapies in prostate cancer	3
Exercise, diet and psychological support for patients with testicular cancer	3
The potential role of the microbiota in prostate cancer pathogenesis and treatment	3
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy	3
Perspectives on chemsex	3
Knockout of extended pelvic lymph node dissection during radical cystectomy	3
A multi-modal approach for decision making in bladder cancer	2
Enhancing spatial transcriptomics in clear-cell renal cell carcinoma	2
Transitional care in urology: the road to independence	2
Applications of AI in urology	2
The urge to advance: ICS 2024 drives innovation in continence care	2
WGC in patients with localized prostate cancer	2
PSMA-targeted fluorescence guidance for robotic-assisted prostatectomy	2
Focusing on male infertility	2
Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence	2
The burden of kidney transplant evaluation — an older adults’ perspective	2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration	2
Effects of the environment on the evolution of the vertebrate urinary tract	2
Adjuvant personalized cancer vaccine: is this the end of metastatic kidney cancer	2
UPEC-mediated alteration of host mitochondrial function — a survival strategy	2
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium	2
ctDNA-guided treatment decisions in muscle-invasive bladder cancer	2
Does immune cell exhaustion lie at the heart of BCG-unresponsive disease?	2
An epigenomic atlas for RCC	2
Patient-reported toxic effects of hypofractionated versus conventional RT	2
Better PrEParation for HIV prevention in minority groups	2
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence	2
Electrical stimulation for the hypocontractile bladder	2
Robotic kidney transplantation	2
Microplastics in the penis	2
Intravesical ICIs to reduce toxicity in NMIBC	2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research	2
AI for drug discovery	2
Reply to ‘Should we screen for sleep apnoea in men with idiopathic infertility?’	2
Quantum computing in surgery and urology — taking a quantum leap	2
Artificial intelligence in academic writing: a paradigm-shifting technological advance	2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer	2
EAU à la mode	2
Metabolic flexibility in ccRCC	2
PROTACs for prostate cancer	2
Molecular and therapeutic landscape of non-clear cell renal carcinoma	2
20 years of ‘spilling the tea’ in urology	2
Key lessons from AI in other endoscopic disciplines to guide the future in cystoscopy	2
Abortion is a urology workforce issue	2
Melon seed extract protects against testis metal toxicity	1
Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction	1
Biomarkers of disease recurrence in stage I testicular germ cell tumours	1
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System	1
Temporary cessation versus continued TKI therapy for RCC	1
Understanding and managing the cardiovascular risks of androgen deprivation therapy for prostate cancer	1
The yin and yang of chromosomal instability in prostate cancer	1
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma	1
20 years of taxane therapy in prostate cancer — the past, present and future	1
Treatment de-escalation for stage II seminoma	1
Endocrine-disrupting chemicals as prostate carcinogens	1